AU2003275712A1 - H17t213-transgenic animal, novel h17t213 protein and dna thereof - Google Patents

H17t213-transgenic animal, novel h17t213 protein and dna thereof

Info

Publication number: AU2003275712A1
Authority: AU; Australia
Prior art keywords: dna; protein; novel; transgenic animal; transgenic
Prior art date: 2002-10-29
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2003275712A

Inventor

Yoshihiko Kaisho

Ikuo Mori

Shigehisa Taketomi

Takuya Watanabe

Yoshitaka Yasuhara

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Takeda Pharmaceutical Co Ltd

Original Assignee

Takeda Chemical Industries Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-10-29

Filing date

2003-10-28

Publication date

2004-05-25

2003-10-28 Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd

2004-05-25 Publication of AU2003275712A1 publication Critical patent/AU2003275712A1/en

Status Abandoned legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/027—New or modified breeds of vertebrates
- A01K67/0275—Genetically modified vertebrates, e.g. transgenic
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2227/00—Animals characterised by species
- A01K2227/10—Mammal
- A01K2227/105—Murine
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/03—Animal model, e.g. for test or diseases
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Engineering & Computer Science (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Genetics & Genomics (AREA)
Zoology (AREA)
Molecular Biology (AREA)
Biomedical Technology (AREA)
Biotechnology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
General Engineering & Computer Science (AREA)
Environmental Sciences (AREA)
Wood Science & Technology (AREA)
Toxicology (AREA)
Pain & Pain Management (AREA)
Neurology (AREA)
Dermatology (AREA)
Ophthalmology & Optometry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Neurosurgery (AREA)
Gastroenterology & Hepatology (AREA)
Epidemiology (AREA)
Cell Biology (AREA)
Immunology (AREA)
Urology & Nephrology (AREA)
Physics & Mathematics (AREA)
Microbiology (AREA)
Biodiversity & Conservation Biology (AREA)

AU2003275712A 2002-10-29 2003-10-28 H17t213-transgenic animal, novel h17t213 protein and dna thereof Abandoned AU2003275712A1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
JP2002-314141		2002-10-29
JP2002314141		2002-10-29
PCT/JP2003/013781 WO2004039972A1 (en)	2002-10-29	2003-10-28	H17t213-transgenic animal, novel h17t213 protein and dna thereof

Publications (1)

Publication Number	Publication Date
AU2003275712A1 true AU2003275712A1 (en)	2004-05-25

Family

ID=32211604

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2003275712A Abandoned AU2003275712A1 (en)	2002-10-29	2003-10-28	H17t213-transgenic animal, novel h17t213 protein and dna thereof

Country Status (2)

Country	Link
AU (1)	AU2003275712A1 (en)
WO (1)	WO2004039972A1 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2000020455A1 (en) *	1998-10-01	2000-04-13	Takeda Chemical Industries, Ltd.	Novel g protein-coupled receptor protein and dna thereof
JP2003533188A (en) *	2000-05-04	2003-11-11	カリフォルニアインスティチュートオブテクノロジー	Pain signaling molecule

2003
- 2003-10-28 WO PCT/JP2003/013781 patent/WO2004039972A1/en not_active Ceased
- 2003-10-28 AU AU2003275712A patent/AU2003275712A1/en not_active Abandoned

Also Published As

Publication number	Publication date
WO2004039972A1 (en)	2004-05-13

Publication	Publication Date	Title
DE60329983D1 (en)	2009-12-24	WAXESESYNTHASE DNA SEQUENCE, PROTEIN AND USES THEREOF
AU2002314181A1 (en)	2003-03-03	Novel endothelially expressed dnas and proteins, and their use
AU2003280084A1 (en)	2004-04-30	Protein arrays and uses thereof
AU2001274566A1 (en)	2002-01-02	Novel protein and dna thereof
EP1585760A4 (en)	2006-06-21	Btl-ii nucleic acids, proteins, and antibodies
AU2003235096A1 (en)	2003-11-10	Novel protein and dna thereof
AU2003275712A1 (en)	2004-05-25	H17t213-transgenic animal, novel h17t213 protein and dna thereof
AU2003262080A1 (en)	2004-04-30	Novel protein and dna thereof
AU2003202694A1 (en)	2003-09-02	Torero protein
AU2003258658A1 (en)	2004-03-19	Improved dna and proteins
AU2003231478A1 (en)	2003-12-02	Novel protein, its dna and use thereof
AU2003236041A1 (en)	2003-10-27	Novel protein and dna thereof
AU2003278718A1 (en)	2004-03-11	Stars-a muscle-specification-binding protein
AU2003203266A1 (en)	2003-09-02	Novel protein, its dna and use thereof
AU2003292721A1 (en)	2004-07-29	Novel protein and its gene
AU2003280641A1 (en)	2004-05-25	Novel protein and dna thereof
AU2003289385A1 (en)	2004-07-09	Novel protein and dna thereof
AU2003272946A1 (en)	2004-05-04	Novel protein and dna thereof
AU2001290565A1 (en)	2002-03-13	Isolated human drug-metabolizing proteins, nucleic acid moleculesand uses thereof
AU2002344618A1 (en)	2003-05-12	Novel protein, its dna and use thereof
EP1602666A4 (en)	2006-05-24	Novel protein and its dna
AU2003211722A1 (en)	2003-09-09	Novel proteins, dnas thereof and use of the same
AU2003220067A1 (en)	2003-09-22	Jade nucleic acids, proteins and uses thereof
AU2003254865A1 (en)	2004-02-25	Akt2-BINDING PROTEIN
AU2003222241A1 (en)	2003-09-16	Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof

Legal Events

Date	Code	Title	Description
2005-07-14	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase